| Anlon Healthcare Ltd | Industry : (Chemicals) | |
|---|---|---|
|
BSE Code : 544497 |
NSE Symbol : AHCL |
P/E(TTM) : 26.40 |
|
ISIN Demat : INE0Y8W01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.55 |
|
Book Value(₹) : 3.95 |
Market Cap(₹Cr) : 771.76 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 30.98 | 55.42 | 35.58 | 52.20 | 33.30 | 48.93 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 30.98 | 55.42 | 35.58 | 52.20 | 33.30 | 48.93 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.06 | 0.01 | 0.20 | 0.03 | 0.01 | 0.04 |
| Total Income | 31.04 | 55.43 | 35.78 | 52.23 | 33.31 | 48.97 |
| Total Expenditure | 23.51 | 41.51 | 23.30 | 38.46 | 27.06 | 31.74 |
| PBIDT | 7.53 | 13.93 | 12.48 | 13.77 | 6.25 | 17.23 |
| Interest | 0.96 | 1.18 | 1.51 | 0.87 | 0.82 | 0.91 |
| PBDT | 6.56 | 12.74 | 10.97 | 12.90 | 5.43 | 16.32 |
| Depreciation | 0.66 | 0.13 | 0.35 | 0.45 | 0.43 | 0.83 |
| Tax | 1.52 | 1.49 | 5.28 | 3.16 | 1.48 | -1.04 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.42 | 1.33 | 0.18 | -0.03 | -0.02 | -0.12 |
| Reported Profit After Tax | 4.80 | 9.79 | 5.15 | 9.32 | 3.55 | 16.65 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 4.80 | 9.79 | 5.15 | 9.32 | 3.55 | 16.65 |
| EPS (Unit Curr.) | 0.09 | 2.15 | 1.13 | 2.22 | 0.89 | 5.15 |
| EPS (Adj) (Unit Curr.) | 0.09 | 0.22 | 0.11 | 0.22 | 0.89 | 5.15 |
| Calculated EPS (Unit Curr.) | 0.09 | 1.84 | 0.97 | 1.75 | 0.67 | 4.18 |
| Calculated EPS (Adj) (Unit Curr.) | 0.09 | 0.18 | 0.10 | 0.17 | 0.67 | 4.18 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.36 | 7.37 | 3.88 | 7.01 | 2.67 | 16.71 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.36 | 0.74 | 0.39 | 0.70 | 2.67 | 16.71 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 106.30 | 53.15 | 53.15 | 53.15 | 53.15 | 39.85 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 24.31 | 25.14 | 35.08 | 26.38 | 18.77 | 35.21 |
| PBDTM(%) | 21.17 | 22.99 | 30.83 | 24.71 | 16.31 | 33.35 |
| PATM(%) | 15.49 | 17.67 | 14.47 | 17.85 | 10.66 | 34.03 |
